WAYNE, Pa., April 30, 2026 (GLOBE NEWSWIRE)-- Palvella Therapeutics, Inc. (Palvella or "the Company”) (Nasdaq: PVLA), a ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Wednesday, May 6, 2026, at 8:30 AM ET to discuss results for the first quarter 2026 and to provide a business ...

Yuanbao Inc. ('Yuanbao” or the 'Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it filed its annual report on Form 20-F for the fiscal ...

SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management ...

Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) ('Vireo”), a multi-state cannabis operator, and FLUENT Corp. (CSE: FNT.U) (OTCQB ...

Aebi Schmidt Holding AG (NASDAQ: AEBI) ('Aebi Schmidt Group” or the 'Company”), a world-class specialty vehicles leader, will announce its first quarter 2026 earnings before the market opens on ...

Hanssen, President and Chief Executive Officer, said "We are pleased to report favorable new enrollment results from the recently completed primary intake cycle in Peru and the secondary intake cycle ...

First Quarter 2026 Revenues of $983.3 Million, Up 9.5% Compared to $898.3 Million in Prior Year QuarterFirst Quarter 2026 EPS of $1.90, Up 9.2% Compared to EPS of $1.74 in Prior Year QuarterCompany ...

Aptose Biosciences Inc. ('Aptose” or the 'Company”) (TSX: APS; OTC: APTOF) announced today that closing of the previously ...

Eric So, Interim CEO, to appear on panel entitled 'The Next Wave of Health Innovation,” on May 4, 2026 NEW YORK and TORONTO, ...

Fuel prices are expected to increase next week. According to local oil industry sources, diesel will go up by P1.50 to P2 per ...

Q1 net sales 11% (organic 8.2%; foreign exchange 0.6%; M&A 2.3%) Q1 operating margin 17.4%; adjusted operating margin 19.8% (up 110 bps y/y) Raising FY 2026 diluted EPS expected range to $17.45-$18.00 ...